SymBio Pharmaceuticals - Top-line data from registrational DLBCL study
SymBio will be presenting data at the European Society of Hematology (EHA) meeting from its pivotal study in Japan of Treakisym (bendamustine) in...
80 Views
SymBio Pharmaceuticals - Treakisym label expansion submitted
SymBio announced on 11 May 2020 that it submitted an application to expand the label for Treakisym in Japan to include the treatment of relapsed...
52 Views
SymBio Pharmaceuticals - Treakisym label expansion submitted
SymBio announced on 11 May 2020 that it submitted an application to expand the label for Treakisym in Japan to include the treatment of relapsed...
42 Views
SymBio Pharmaceuticals - Supply issues continue
SymBio reported sales of $25.8m (¥2.838bn) for 2019 and an operating loss of $39.1 (¥4.301bn). Sales were down from 2018 due to the previously...
598 Views
SymBio Pharmaceuticals - Supply issues continue
SymBio reported sales of ¥2.838bn for 2019 and an operating loss of ¥4.301bn. Sales were down from 2018 due to the previously announced quality...
603 Views